Position in CRSP
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$3,043,550
+$331,014 QoQ
Shares Held
55,804
-2.1% QoQ
Ownership
0.058%
of shares outstanding
% of Portfolio
2.09%
of 13F equity value
Holder Rank
#95
of 519 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CRSP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Green Alpha Advisors, LLC holds $9,323,372 across 14 Biotechnology names. CRSP ranks #1 (32.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
This page
|
55,804 | $3,043,550 | |
| 2 | MRNA |
Moderna, Inc.
|
33,758 | $2,364,072 | |
| 3 | PRME |
Prime Medicine, Inc.
|
185,023 | $682,734 | |
| 4 | CRBU |
Caribou Biosciences, Inc.
|
364,324 | $641,210 | |
| 5 | RXRX |
Recursion Pharmaceuticals, Inc.
|
147,544 | $541,486 | |
| 6 | EDIT |
Editas Medicine, Inc.
|
156,046 | $505,589 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
552 | $274,194 | |
| 8 | BEAM |
Beam Therapeutics Inc.
|
7,569 | $259,768 |
All Filings in CRSP
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,043,550 | 55,804 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $2,712,536 | 57,022 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $2,922,848 | 55,737 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $3,565,327 | 55,012 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $2,843,640 | 58,463 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $1,951,994 | 57,361 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $969,397 | 24,629 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $900,042 | 19,158 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $1,060,594 | 19,637 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,837,320 | 26,956 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $1,536,830 | 24,550 | Shares | Sole | 2024-01-05 | |
| 2023-09-30 | $1,583,203 | 34,880 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $1,929,700 | 34,373 | Shares | Sole | 2023-07-06 | |
| 2023-03-31 | $1,473,729 | 32,583 | Shares | Sole | 2023-04-06 | |
| 2022-12-31 | $1,245,759 | 30,646 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $1,794,903 | 27,466 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $13,872,940 | 228,286 | Shares | Sole | 2022-07-08 | |
| 2022-03-31 | $1,602,706 | 25,533 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $1,300,309 | 17,159 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $1,670,219 | 14,922 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $2,057,298 | 12,708 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $827,848 | 6,794 | Shares | Sole | 2021-07-22 | |
| 2020-12-31 | $972,554 | 6,352 | Shares | Sole | 2021-07-22 | |
| No filing history on record for this holder in this stock. | ||||||